CNA·3 min read·medium
Malaysia targets 2028 to produce its first human vaccine to cut import reliance
C
CNA
✦AI Summary
Malaysia aims to produce its first locally manufactured human vaccine by 2028 to reduce dependence on imports. The project involves a technology transfer partnership with a Chinese firm to produce the PCV13 vaccine.
Malaysia’s first locally produced human vaccine will be for treating illnesses like pneumonia, meningitis, sepsis and blood infections, says Science, Technology and Innovation Minister Chang Lih Kang.
healthbusinessscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in